Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Detection of Immune Checkpoint Receptors – A Current Challenge in Clinical Flow Cytometry
Benjamin Shibru, Katharina Fey, Stephan Fricke, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Mechanisms of immune checkpoint inhibitors: insights into the regulation of circular RNAS involved in cancer hallmarks
Lingjiao Meng, Haotian Wu, Jiaxiang Wu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 56
GAPDH: A common housekeeping gene with an oncogenic role in pan-cancer
Jin Wang, Xueting Yu, Xiyuan Cao, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 4056-4069
Open Access | Times Cited: 26
Circular RNAs in tumor immunity and immunotherapy
Wenjie Zhang, Xu Chen, Zhipeng Yang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 9
High-dimensional multi-pass flow cytometry via spectrally encoded cellular barcoding
Sheldon J. J. Kwok, Sarah Forward, Marissa Fahlberg, et al.
Nature Biomedical Engineering (2023) Vol. 8, Iss. 3, pp. 310-324
Open Access | Times Cited: 17
Uncovering the flip side of immune checkpoint inhibitors: a comprehensive review of immune-related adverse events and predictive biomarkers
Yandong Miao, Wuxia Quan, Xiaolong Tang, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 2, pp. 621-642
Open Access | Times Cited: 6
Adenosine-modulating synthetic high-density lipoprotein for chemoimmunotherapy of triple-negative breast cancer
Xiang Gong, Chao Zheng, Ying Cai, et al.
Journal of Controlled Release (2024) Vol. 367, pp. 637-648
Closed Access | Times Cited: 5
Enhanced cellular therapy: revolutionizing adoptive cellular therapy
Mengyao Xu, Na Zeng, Chen‐Qian Liu, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Retinol-Binding Protein 4 as a Biomarker in Cancer: Insights from a Pan-Cancer Analysis of Expression, Immune Infiltration, and Methylation
Jia Zhao, Yaxin Liu, Lingqin Zhou, et al.
Genes (2025) Vol. 16, Iss. 2, pp. 150-150
Open Access
A comprehensive prognostic and immunological analysis of hexokinase domain containing protein-1 (HKDC1) in pan-cancer
Zhi Liang, Tian-hao Zhang, Jiajia Huang, et al.
PeerJ (2025) Vol. 13, pp. e19083-e19083
Open Access
Advancing Glioblastoma Therapy: Learning From the Past and Innovations for the Future
Mandeep Rana, Ke-Chi Liou, Amandeep Thakur, et al.
Cancer Letters (2025), pp. 217601-217601
Closed Access
Cell-free chromatin particles released from dying cancer cells activate immune checkpoints in human lymphocytes: implications for cancer therapy
Snehal Shabrish, Kavita Pal, Naveen Kumar Khare, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 3
Immune checkpoint inhibitors for the treatment of sepsis:insights from preclinical and clinical development
Mario Rienzo, Tomasz Skirecki, Guillaume Monneret, et al.
Expert Opinion on Investigational Drugs (2022) Vol. 31, Iss. 9, pp. 885-894
Closed Access | Times Cited: 15
On Demand Biosensors for Early Diagnosis of Cancer and Immune Checkpoints Blockade Therapy Monitoring from Liquid Biopsy
Sai Mummareddy, Stuti Pradhan, Ashwin Kumar Narasimhan, et al.
Biosensors (2021) Vol. 11, Iss. 12, pp. 500-500
Open Access | Times Cited: 20
Identification of an ADME-related gene for forecasting the prognosis and responding to immunotherapy in sarcomas
Jianlong Wang, Guowei Wang, Tianrui Hu, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 2
The PD-1 with PD-L1 Axis Is Pertinent with the Immune Modulation of Atrial Fibrillation by Regulating T Cell Excitation and Promoting the Secretion of Inflammatory Factors
Guodong Chang, Yingwei Chen, Zichang Liu, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-7
Open Access | Times Cited: 12
BTN3A: A Promising Immune Checkpoint for Cancer Prognosis and Treatment
Abdou-samad Kone, Saadia Ait Ssi, S. Sahraoui, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13424-13424
Open Access | Times Cited: 12
Immune checkpoint blockade for locally advanced or recurrent/metastatic cervical cancer: An update on clinical data
Zhuo Song, Kun Zou, Lijuan Zou
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 11
A maladaptive pleural environment suppresses preexisting anti-tumor activity of pleural infiltrating T cells
Vera S. Donnenberg, James D. Luketich, Ibrahim Sultan, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Identifying immune checkpoint-related lncRNA biomarkers for immunotherapy response and prognosis in cancers
Yue Gao, Xinyue Wang, Longlong Dong, et al.
Scientific Data (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Constructing and Evaluating a Mitophagy-Related Gene Prognostic Model: Implications for Immune Landscape and Tumor Biology in Lung Adenocarcinoma
Jin Wang, Kaifan Liu, Jiawen Li, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 228-228
Open Access | Times Cited: 1
Computational and Systems Biology Advances to Enable Bioagent Agnostic Signatures
Andy Lin, Cameron Torres, Errett C. Hobbs, et al.
Health Security (2024) Vol. 22, Iss. 2, pp. 130-139
Open Access | Times Cited: 1
The interplay between metabolic adaptations and diet in cancer immunotherapy
Lena Espelage, Natalie Wagner, Jan‐Malte Placke, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 15, pp. 3117-3127
Closed Access | Times Cited: 1
Identification and validation of potential prognostic biomarkers in glioblastoma via the mesenchymal stem cell infiltration level
Shengyu Wang, Senlin Mao, Xiaofu Li, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
NEK2 is a potential pan-cancer biomarker and immunotherapy target
Lanyue Zhang, Yang Li, Juexiao Deng, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Association Between VISTA and Vascular Cognitive Impairment in Older Chinese Adults: A Cross-Sectional Study
Shilin Liu, Lifang Chi
Clinical Interventions in Aging (2024) Vol. Volume 19, pp. 1939-1949
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top